Anna Maria Zanellato,Vincenza Corsa,Giancarlo Carpanese,Monica Campisi
申请号：
US14389301
公开号：
US09655918B2
申请日:
2013.03.27
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following osteochondral surgery. These formulations are also suitable for the treatment of interstitial cystitis.
